Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,336,798
-$9,902,471 QoQ
Shares Held
1,816,907
-5.0% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. CRMD ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,336,798 | 1,816,907 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,239,269 | 1,912,233 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,047,648 | 1,809,772 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $19,666,686 | 1,596,322 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,826,780 | 1,432,919 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,281,841 | 1,392,820 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,378,469 | 1,284,464 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,504,698 | 1,271,293 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,016,649 | 1,183,172 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,357,118 | 1,158,808 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,996,999 | 1,080,270 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,378,724 | 851,064 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,506,189 | 356,917 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $989,639 | 349,696 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,330,435 | 330,954 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,624,455 | 661,397 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,927,733 | 643,458 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,120,163 | 671,003 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,328,954 | 631,043 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,328,226 | 533,356 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,415,890 | 459,743 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,483,419 | 411,844 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,287,693 | 363,126 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,280,574 | 356,706 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||